Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biote Q2 EPS $0.10 Beats $0.06 Estimate, Sales $48.90M Miss $49.52M Estimate

Author: Benzinga Newsdesk | August 06, 2025 03:07pm
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $0.06 by 58.73 percent. This is a 152.63 percent increase over losses of $(0.19) per share from the same period last year. The company reported quarterly sales of $48.90 million which missed the analyst consensus estimate of $49.52 million by 1.26 percent. This is a 0.55 percent decrease over sales of $49.17 million the same period last year.

Posted In: BTMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist